The Quality of Life Impact of Participation in a Head and Neck Cancer Support Group

2005 ◽  
Vol 133 (2) ◽  
pp. P208-P209
Author(s):  
S WANG ◽  
M ALI
2007 ◽  
Vol 136 (3) ◽  
pp. 405-410 ◽  
Author(s):  
Kalpesh T. Vakharia ◽  
M. Jafer Ali ◽  
Steven J. Wang

2018 ◽  
Vol 159 (5) ◽  
pp. 853-858 ◽  
Author(s):  
John D. Cramer ◽  
Jonas T. Johnson ◽  
Marci L. Nilsen

Objectives Pain is common among patients with cancer, stemming from both malignancy and side effects of treatment. The extent to which pain persists after treatment has received little attention. We examined the prevalence, predictors, and impact on quality of life (QOL) caused by pain among survivors of head and neck cancer. Study Design Cohort study. Setting Tertiary head and neck cancer survivorship clinic. Subjects and Methods We identified survivors of head and neck cancer ≥1 year after diagnosis and examined the prevalence and risk factors for development of pain. Pain and QOL were assessed with multiple QOL instruments. Ordinal regression modeling examined predictors of pain in survivors. Results We identified 175 patients at a median of 6.6 years after diagnosis. Among survivors, 45.1% reported pain, and 11.5% reported severe pain. Among patients with current pain, 46% reported low overall QOL versus only 12% of those without pain ( P < .001). On multivariable analysis after adjustment for age, sex, and stage of disease, pain was associated with trimodality treatment (odds ratio [OR], 3.55; 95% CI, 1.06-12.77). Multivariable analysis of QOL issues revealed that pain was associated with major depression (OR, 3.91; 95% CI, 1.68-9.11), anxiety (OR, 4.22; 95% CI, 2.28-7.81), poor recreation (OR, 3.31; 95% CI, 1.70-6.48), and low overall QOL (OR, 2.20; 95% CI, 1.12-4.34). Conclusions Years after head and neck cancer treatment, pain remains a significant problem and is associated with worse QOL. Future efforts should focus on preventing pain from treatment and comprehensive management.


ASHA Leader ◽  
2010 ◽  
Vol 15 (4) ◽  
Author(s):  
Sara Chaney ◽  
Kathy Groves-Wright ◽  
Nancy Creaghead

Author(s):  
Kyohei Itamura ◽  
David Lam ◽  
Brian Cameron ◽  
Tamara Chambers ◽  
Niels Kokot ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
Sarah E. Mowry ◽  
Marilene B. Wang

Objective. To compare quality of life in head and neck cancer (HNC) patients following treatment. Methods. The Short Form-36 Version 2 (SF-36v2) was utilized to measure patient quality of life. Results. For all 8 parameters measured by the SF-36V2, HNC patients had lower mean scores than the US population means. Support group patients had significantly worse scores than US population norms in role-physical, social functioning, and role-emotional. There were no significant differences between support group and control patients for the 8 parameters measured by the SF-36v2. Conclusions. HNC patients report significantly worse quality of life than US population norms in several physical and emotional areas. Our study did not demonstrate improved quality of life for support group patients. The increased incidence of oropharyngeal cancer and chemotherapy treatment in the support group patients in our study were factors which were likely to have lowered the overall scores in these patients.


2012 ◽  
Vol 3 (1) ◽  
pp. e11-e23 ◽  
Author(s):  
Shelagh M. Szabo ◽  
Rosie L. Dobson ◽  
Bonnie M.K. Donato ◽  
Gil L’Italien ◽  
Sebastien J. Hotte ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document